產(chǎn)品詳情
簡單介紹：
Anti-Cytokeratin 19抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-Cytokeratin 19抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-Cytokeratin 19
Cat. Number:
Anti-Cytokeratin 19抗體KL-1028R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
The protein encoded by Anti-Cytokeratin 19抗體this gene is a member of the keratin family. The keratins are intermediate filament proteins responsible for the structural integrity of epithelial cells and are subdivided into cytokeratins and hair keratins. The type I cytokeratins consist of acidic proteins which are arranged in pairs of heterotypic keratin chains. Unlike its related family members, this smallest known acidic cytokeratin is not paired with a basic cytokeratin in epithelial cells. It is specifically expressed in the periderm, the transiently superficial layer that envelopes the developing epidermis. The type I cytokeratins are clustered in a region of chromosome 17q12-q21. [provided by RefSeq, Jul 2008]
Also known as:
40 kDa keratin intermediate Anti-Cytokeratin 19抗體filament; CK 19; ck19; CK19; CK-19; KRT19; Cytokeratin 19; Cytokeratin-19; k19; k1cs; Keratin 19; Keratin-19; Keratin type I 40 kD; Keratin type i 40kD; Keratin type I cytoskeletal 19; krt19; mgc15366; K1C19_HUMAN; Keratin, type I cytoskeletal 19; Keratin, type I, 40 kd.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, .
●
Immunogen: KLH conjugated synthetic peptide derived from human CK19.
●
Predicted Molecular Weight:Anti-Cytokeratin 19抗體 44kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutionsAnti-Cytokeratin 19抗體 must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutionsAnti-Cytokeratin 19抗體 must be determined by the end user.
kl147Bo01 脂聯(lián)素受體1(ADIPOR1)多克隆抗體 Polyclonal Antibody to Adiponectin Receptor 1 (ADIPOR1)
kl147Ga01 脂聯(lián)素受體1(ADIPOR1)多克隆抗體 Polyclonal Antibody to Adiponectin Receptor 1 (ADIPOR1)
kl147Hu01 脂聯(lián)素受體1(ADIPOR1)多克隆抗體 Polyclonal Antibody to Adiponectin Receptor 1 (ADIPOR1)
kl147Mu01 脂聯(lián)素受體1(ADIPOR1)多克隆抗體 Polyclonal Antibody to Adiponectin Receptor 1 (ADIPOR1)
kl147Po01 脂聯(lián)素受體1(ADIPOR1)多克隆抗體 Polyclonal Antibody to Adiponectin Receptor 1 (ADIPOR1)
kl147Ra01 脂聯(lián)素受體1(ADIPOR1)多克隆抗體 Polyclonal Antibody to Adiponectin Receptor 1 (ADIPOR1)
kl147Si01 脂聯(lián)素受體1(ADIPOR1)多克隆抗體 Polyclonal Antibody to Adiponectin Receptor 1 (ADIPOR1)
kl149Hu01 Ⅳ型膠原α1(COL4α1)多克隆抗體 Polyclonal Antibody to Collagen Type IV Alpha 1 (COL4a1)
kl149Mu01 Ⅳ型膠原α1(COL4α1)多克隆抗體 Polyclonal Antibody to Collagen Type IV Alpha 1 (COL4a1)
kl149Ra01 Ⅳ型膠原α1(COL4α1)多克隆抗體 Polyclonal Antibody to Collagen Type IV Alpha 1 (COL4a1)
kl151Mu01 激肽釋放酶3(KLK3)多克隆抗體 Polyclonal Antibody to Kallikrein 3 (KLK3)
kl151Si01 激肽釋放酶3(KLK3)多克隆抗體 Polyclonal Antibody to Kallikrein 3 (KLK3)
kl154Hu01 糖抗原125(CA125)多克隆抗體 Polyclonal Antibody to Carbohydrate Antigen 125 (CA125)
kl154Mu01 糖抗原125(CA125)多克隆抗體 Polyclonal Antibody to Carbohydrate Antigen 125 (CA125)
kl159Hu01 鱗狀細(xì)胞癌抗原2(SCCA2)多克隆抗體 Polyclonal Antibody to Squamous Cell Carcinoma Antigen 2 (SCCA2)
kl159Mu01 鱗狀細(xì)胞癌抗原2(SCCA2)多克隆抗體 Polyclonal Antibody to Squamous Cell Carcinoma Antigen 2 (SCCA2)
kl160Bo01 α2-纖溶酶抑制因子(α2PI)多克隆抗體 Polyclonal Antibody to Alpha-2-Plasmin Inhibitor (a2PI)
kl160Hu01 α2-纖溶酶抑制因子(α2PI)多克隆抗體 Polyclonal Antibody to Alpha-2-Plasmin Inhibitor (a2PI)
kl160Mu01 α2-纖溶酶抑制因子(α2PI)多克隆抗體 Polyclonal Antibody to Alpha-2-Plasmin Inhibitor (a2PI)
kl160Ra01 α2-纖溶酶抑制因子(α2PI)多克隆抗體 Polyclonal Antibody to Alpha-2-Plasmin Inhibitor (a2PI)
kl160Rb51 α2-纖溶酶抑制因子(α2PI)多克隆抗體 Polyclonal Antibody to Alpha-2-Plasmin Inhibitor (a2PI)
